Robin Walsh | Advisor-Toxicology, Immunosafety
Eli Lilly and Company

Robin Walsh, Advisor-Toxicology, Immunosafety, Eli Lilly and Company

Appearances:



Festival of Biologics Day 3 @ 11:30

Preclinical Immunogenicity Risk Assessment using CD4 T cell Assays

last published: 16/Apr/24 22:55 GMT

back to speakers